YS Biopharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Fung Ching Wong(52.23%),Apex Prospect Limited(52.23%)
YS Biopharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Fung Ching Wong(52.23%),Apex Prospect Limited(52.23%)
YS Biopharma | SC 13D：超過5%持股股東披露文件-Fung Ching Wong(52.23%),Apex Prospect Limited(52.23%)
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間